Immunai

About:

Immunai is a biotech company that provides mapping and reprogramming immunology, machine learning, and software engineering.

Website: https://www.immunai.com

Twitter/X: Immunaitech

Top Investors: 8VC, Alexandria Venture Investments, Catalio Capital Management, TLV Partners, Koch Disruptive Technologies

Description:

Immunai is a biotech company that combines single-cell genomics with ML algorithms to enable high-resolution profiling of the immune system. Immunai's mission is to map the entire immune system and its functions using single-cell genomics and machine learning. Immunai leverages single-cell technologies to profile cells from a blood sample, and uses machine-learning algorithms (powered by its proprietary database) to map the hundreds of cell types and their states to create an immune profile. They work on biomarker discovery and insights that identify how a cell responds to its changing environment. The company is located in New York City, San Francisco, and Tel Aviv, Israel.